Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
drug prices
genentech
nash
pfizer
2019
abiraterone
ac immune
acc
acorda therapeutics
acquisition
What
bio
drug
3
×
roundup
gene
adu
advanced
alnylam’s
alzheimer’s
approval
approved
beats
bff
bids
biogen
companies
complicated
conference
deals
depression
devoted
different
dire
disease
easl
fail
form
good
group
heart
help
increases
kicked
latest
liver
major
medical
need
news
people
pharmaceutical
Language
Current search:
sanofi
×
celgene
×
drug
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More